How will CDMO boost the market growth?
CDMO Market report from DelveInsight provides an in-depth analysis of CDMO, as well as historical and forecasted market trends in the global market (North-America, Europe, Asia Pacific and Rest of the world).
What is CDMO?
Contract Development and Manufacturing Organizations are entities that are involved in the drug development process starting from initial development to product manufacturing as well as packaging of the drugs providing end-to-end solutions to pharmaceutical companies.
To Know in detail about the CDMO market outlook, treatment scenario and market trends, Click here; CDMO Market Insights
What are the Key Highlights from CDMO Market Report?
The CDMO market size was valued at USD 100.02 Billion in the year 2021 and is expected to grow at a CAGR of 6.25% during the forecasted period (2022-2027). In February 2022, a China-based CDMO Asymchem Inc. plans to buy Snapdragon Chemistry, a US-based company focused on continuous manufacturing and early-stage chemical process development services for the total value of USD 57.94 million. This transaction is aimed at the expansion of the business of the Chinese CDMO in the US. In February 2022, MilliporeSigma, the U.S. and Canada Life Science business sector of Merck KGaA closed the transaction marking the acquisition of Exelead for approximately USD 780 million in cash. This is expected to add to the capabilities of the LifeSciences business in becoming one the prominent CDMOs in the mRNA value chain. In February 2021, EQT, a buyout group, announced the acquisition of Recipharm through public takeover for USD 2.8 billion.
CDMO Market Drivers - Regulatory hurdles in gaining product approvals, Rising disease prevalence, Increase demand for CDMO services, and Rising prevalence of geriatric population. CDMO Market Barriers- high cost of CDMO services, complications related to surgical procedures such as data security & privacy issues
Request a sample for the Report:
The market report on CDMO includes an overview of the industry as well as a PEST Analysis. The report also examines market drivers, market constraints, and unmet medical needs in order to identify the greatest prospects and analyze the market's underlying potential.
CDMO Market Insights:
Growing demand for drugs due to factors like rising disease prevalence and the popularity of biologics as a treatment option are also predicted to increase demand for CDMO services because biologics require more sophisticated facilities for product development than small molecules do. Furthermore, a number of strategic alliances have been formed to support the CDMO industry as a result of the benefits that CDMOs provide.
The CDMO market has been occupied by some leading companies in the manufacturing of the CDMO depending on the geography, drugs and service type.
The CDMO market is broad, with a large variety of products accessible, and CDMO key companies such as Patheon (Thermo Fisher Scientific), Catalent,Inc, Laboratoire Elaiapharm, The Lubrizol Corporation, Cambrex Corporation, Recipharm (EQT), Merck & Co., Inc, AGC Biologics, Nerpharma S.r.l, Pfizer CenterOne (Pfizer Inc), EMERGENT, Onyx Scientific Limited, Lonza, Siegfried Holding AG, CordenPharma International, FUJIFILM Diosynth Biotechnologies, Samsung Biologics, Delpharm, Center for Breakthrough Medicines, and WuXi Biologics, are present.
What are the key benefits of the CDMO market report?
CDMO market report covers a descriptive overview and comprehensive insight of the CDMO market trends and CDMO market globally.
CDMO market report provides a global historical and forecasted market covering drug outreach globally.
The CDMO market report offers an edge that will help develop business strategies by understanding trends shaping and driving the CDMO market.
Comments
Post a Comment